Ikena Oncology Future Growth
Future criteria checks 2/6
Ikena Oncology's earnings are forecast to decline at 2.7% per annum while its annual revenue is expected to grow at 42.3% per year. EPS is expected to grow by 4.7% per annum.
Key information
-2.7%
Earnings growth rate
4.7%
EPS growth rate
| Pharmaceuticals earnings growth | 20.9% |
| Revenue growth rate | 42.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 19 Mar 2024 |
Recent future growth updates
Recent updates
Growth Investors: Industry Analysts Just Upgraded Their Ikena Oncology, Inc. (NASDAQ:IKNA) Revenue Forecasts By 31%
Nov 10
Analysts Just Slashed Their Ikena Oncology, Inc. (NASDAQ:IKNA) EPS Numbers
Aug 15Need To Know: Analysts Are Much More Bullish On Ikena Oncology, Inc. (NASDAQ:IKNA) Revenues
May 20Will Ikena Oncology (NASDAQ:IKNA) Spend Its Cash Wisely?
Apr 29We Think Ikena Oncology (NASDAQ:IKNA) Needs To Drive Business Growth Carefully
Jan 06Companies Like Ikena Oncology (NASDAQ:IKNA) Are In A Position To Invest In Growth
Aug 06Party Time: Brokers Just Made Major Increases To Their Ikena Oncology, Inc. (NASDAQ:IKNA) Earnings Forecasts
Mar 23Ikena Oncology, Inc. (NASDAQ:IKNA) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Mar 21Is Ikena Oncology (NASDAQ:IKNA) In A Good Position To Deliver On Growth Plans?
Feb 19We're Not Very Worried About Ikena Oncology's (NASDAQ:IKNA) Cash Burn Rate
Nov 02Ikena Oncology (NASDAQ:IKNA) Is In A Good Position To Deliver On Growth Plans
Jul 13Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 15 | -86 | -97 | N/A | 5 |
| 12/31/2025 | 11 | -81 | -92 | N/A | 5 |
| 12/31/2024 | 7 | -75 | -82 | N/A | 4 |
| 12/31/2023 | 9 | -68 | -80 | -80 | N/A |
| 9/30/2023 | 14 | -63 | -76 | -76 | N/A |
| 6/30/2023 | 19 | -63 | -74 | -73 | N/A |
| 3/31/2023 | 18 | -66 | -76 | -74 | N/A |
| 12/31/2022 | 16 | -69 | -76 | -74 | N/A |
| 9/30/2022 | 30 | -52 | -72 | -70 | N/A |
| 6/30/2022 | 28 | -49 | -71 | -71 | N/A |
| 3/31/2022 | 31 | -41 | -68 | -67 | N/A |
| 12/31/2021 | 31 | -34 | -62 | -60 | N/A |
| 9/30/2021 | 11 | -63 | -61 | -59 | N/A |
| 6/30/2021 | 10 | -55 | -51 | -49 | N/A |
| 3/31/2021 | 9 | -47 | -43 | -41 | N/A |
| 12/31/2020 | 9 | -44 | -39 | -38 | N/A |
| 9/30/2020 | 12 | -23 | -34 | -33 | N/A |
| 12/31/2019 | 14 | -17 | 48 | 48 | N/A |
| 12/31/2018 | 1 | -41 | -12 | -12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IKNA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IKNA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IKNA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IKNA's revenue (42.3% per year) is forecast to grow faster than the US market (7.9% per year).
High Growth Revenue: IKNA's revenue (42.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IKNA's Return on Equity is forecast to be high in 3 years time